PREreviews of “High Sensitivity of the BioNote Anigen™ Rapid Rabies Antigen Test in Detection of Diverse Rabies Virus Variants Suggests Utility for Global Rabies Control”

Skip to preprint details Skip to PREreviews

High Sensitivity of the BioNote Anigen™ Rapid Rabies Antigen Test in Detection of Diverse Rabies Virus Variants Suggests Utility for Global Rabies Control

by Lillian A. Orciari, Vaughn Wicker, Sarah Bonaparte, Pamela A. Yager, Claire Hartloge, Kirk Silas, Melanie Seiders, Puja Patel, Annette Regec, Miguel Maldonado-Cedeño, Ramon F. Flores Ramos, Sharon Messenger, Ruth Lopez, Christopher Preas, Alice Price, Kimberlee B. Beckmen, Kristin E. Campbell, Melanie Goff, Chis Vogt, Lisa Wingerter, Kristie L. Schwarzkopf, Yimer Mulugeta, Dessalegn S. Fujaga, Teresa Fields, George Dautu, Pierre Dilius, Crystal Gigante, Edgar Condori, Christina L. Hutson, Panayampalli S. Satheshkumar, and Ryan M. Wallace

Posted: October 27, 2025
Server: medRxiv
DOI: 10.1101/2025.10.25.25338785

Abstract

Point-of-care, immunochromatographic tests have not reliably detected rabies virus and have not utilized a consistent diagnostic protocol. International diagnostic standards established by the World Organization for Animal Health require strategic and large-scale validation studies prior to widescale use. The United States (US) Centers for Disease Control and Prevention, National Rabies Reference Laboratory undertook a large-scale validation of the BioNote Anigen™ Rapid Rabies Antigen Test in collaboration with eight US public health laboratories and three international laboratories. Modifications were made to manufacturer instructions to maximize antigen concentration in the test diluent. A total of 1,399 samples underwent paired testing with one of three US gold standard tests, consisting of 31 types of animals and 9 rabies virus variants. Test sensitivity and specificity was 97.11% (CI: 95.21% - 98.27%) and 99.89% (CI: 99.36% - 99.98%). Fourteen samples resulted in false-negative results, primarily impacting dogs that were euthanized early or shown to have a low viral load. Limit of detection studies found that false-negative results often occurred when the sample had a PCR Ct value > 23. The BioNote Anigen™ Test performed well across diverse RVVs found in North America. Sensitivity of the test was slightly lower than, but not statistically inferior to, the minimum 98% value established for the current gold-standard tests. This is the largest systematic evaluation of a rabies point-of-care test that includes diverse RVV and animal type and results suggest that the BioNote Anigen™ Test with the procedural changes would have broad benefits for rapid diagnosis in animals.

Read the preprint

2 PREreviews

Write a PREreview Request a PREreview

PREreview by Shadow Bee

Authored by Shadow Bee

Summary

This preprint evaluates the performance of the Xpert MTB/XDR assay for rapid detection of drug resistance in Mycobacterium tuberculosis (Mtb) beyond rifampicin, specifically targeting fluoroquinolone and aminoglycoside resistance. The authors compiled a multi-site panel of clinical…

Read the PREreview by Shadow Bee
PREreview by Shadow Bee

Authored by Shadow Bee

This preprint evaluates the performance of the BioNote Anigen Rapid Rabies Antigen Test across a wide diversity of rabies virus variants, including both classical and atypical lineages. The authors report high sensitivity and specificity of the assay compared to gold-standard diagnostic methods,…

Read the PREreview by Shadow Bee

PREreviews of High Sensitivity of the BioNote Anigen™ Rapid Rabies Antigen Test in Detection of Diverse Rabies Virus Variants Suggests Utility for Global Rabies Control

2 PREreviews

Summary

This preprint evaluates the performance of the Xpert MTB/XDR assay for rapid detection of drug resistance in Mycobacterium tuberculosis (Mtb) beyond rifampicin, specifically targeting fluoroquinolone and aminoglycoside resistance. The authors compiled a multi-site panel of clinical…